Citation tools
"A Novel, Orally Active CXCR1/2 Receptor Antagonist, Sch527123, Inhibits Neutrophil Recruitment, Mucus Production, and Goblet Cell Hyperplasia in Animal Models of Pulmonary Inflammation." Journal of Pharmacology and Experimental Therapeutics
322.2
(2007):
486-493.
Web. 31 Jan. 2023.